(Health-NewsWire.Net, March 19, 2017 ) A strong trend of R&D investments in Food & Beverage industries will majorly drive this industry. Other growth drivers include the need to curtail costs, growth and increased use of shifting commodity prices, strength of private label brands and increased competition...
(Health-NewsWire.Net, March 19, 2017 ) A strong trend of R&D investments in Food & Beverage industries will majorly drive this industry. Other growth drivers include the need to curtail costs, growth and increased use of shifting commodity prices, strength of private label brands and increased competition...
(Health-NewsWire.Net, March 19, 2017 ) A strong trend of R&D investments in Food & Beverage industries will majorly drive this industry. Other growth drivers include the need to curtail costs, growth and increased use of shifting commodity prices, strength of private label brands and increased competition...
(Health-NewsWire.Net, March 18, 2017 ) The Photo Colposcope Market analysis of an industry is a crucial thing for various stakeholders like investors, CEOs, traders, suppliers and others. The Photo Colposcope Market industry research report is a resource, which provides current as well as upcoming...
(Health-NewsWire.Net, March 18, 2017 ) The Pharmaceutical Testing Services Market analysis of an industry is a crucial thing for various stakeholders like investors, CEOs, traders, suppliers and others. The Pharmaceutical Testing Services Market industry research report is a resource, which provides...
(Health-NewsWire.Net, March 18, 2017 ) The report “Respiratory Diagnostics Market - Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to...
(Health-NewsWire.Net, March 18, 2017 ) "Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors. The Publisher's...
(Health-NewsWire.Net, March 18, 2017 ) Publisher's, "NMDA Receptor 2B Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the NMDA Receptor 2B Antagonists. The Publisher's Report covers the product profiles in various...
(Health-NewsWire.Net, March 18, 2017 ) Publisher Drug Report, "Invanz- Drug Insights, 2016" highlights the Invanz marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Invanz covering the total...
(Health-NewsWire.Net, March 18, 2017 ) Publisher Drug Report, "Boostrix- Drug Insights, 2016" highlights the Boostrix marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Boostrix covering the...
(Health-NewsWire.Net, March 18, 2017 ) According to Publisher, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting for self administered treatment and care there...
(Health-NewsWire.Net, March 18, 2017 ) According to Publisher, the Medical Radiation Detection Market accounted for $0.87 billion in 2015 and is expected to reach $1.58 billion by 2022 growing at a CAGR of 8.8% from 2015 to 2022. Increasing incidences of cancer and rising healthcare industry worldwide...
(Health-NewsWire.Net, March 20, 2017 ) According to Publisher, the Global Polymerase Chain Reaction market is accounted for $6.95 billion in 2015 and is expected to reach $12.56 billion by 2022 growing at a CAGR of 8.8% during the forecast period. Increasing investments in gene therapy and government...
(Health-NewsWire.Net, March 20, 2017 ) According to Publisher, the Bone Marrow Transplant market accounted for $10.58 billion in 2015 and is expected to reach $15.95 billion by 2022 growing at a CAGR of 6.0% from 2015 to 2022. Occurrence of blood cancers and increasing investment in logistic services...
(Health-NewsWire.Net, March 20, 2017 ) According to Publisher, the Global Nuclear Medicine Market is valued at $4.42 billion in 2015 and is expected to grow at a CAGR of 10.55 % to reach $8.92 billion by 2022. Rising demand from emerging nations and the growing incidence of cardiovascular ailments...
|